|
Combination Products Proposed Rule Provides Streamlined GMP Option
Makers of components in co-packaged or single-entity combination products marketed in the U.S. would have two options for showing compliance with quality system (QS) requirements for devices and current good manufacturing practices (cGMPs) for drugs or biologics under a new proposed rule.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives